1
|
Ramanathan G, Elumalai R, Periyasamy S and
Lakkakula B: Role of renin-angiotensin-aldosterone system gene
polymorphisms and hypertension-induced end-stage renal disease in
autosomal dominant polycystic kidney disease. Iran J Kidney Dis.
8:265–277. 2014.PubMed/NCBI
|
2
|
Higashihara E, Nutahara K, Kojima M,
Tamakoshi A, Yoshiyuki O, Sakai H and Kurokawa K: Prevalence and
renal prognosis of diagnosed autosomal dominant polycystic kidney
disease in Japan. Nephron. 80:421–427. 1998. View Article : Google Scholar : PubMed/NCBI
|
3
|
Utsumi T, Kawamura K, Imamoto T, Nagano H,
Tanaka T, Kamiya N, Nihei N, Naya Y, Suzuki H and Ichikawa T:
Preoperative masked renal damage in Japanese patients with primary
aldosteronism: Identification of predictors for chronic kidney
disease manifested after adrenalectomy. Int J Urol. 20:685–691.
2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Iwakura Y, Morimoto R, Kudo M, Ono Y,
Takase K, Seiji K, Arai Y, Nakamura Y, Sasano H, Ito S and Satoh F:
Predictors of decreasing glomerular filtration rate and prevalence
of chronic kidney disease after treatment of primary aldosteronism:
Renal outcome of 213 cases. J Clin Endocrinol Metab. 99:1593–1598.
2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Tanase-Nakao K, Naruse M, Nanba K, Tsuiki
M, Tagami T, Usui T, Okuno H, Shimatsu A, Hashimoto S, Katabami T,
et al: Chronic kidney disease score for predicting postoperative
masked renal insufficiency in patients with primary aldosteronism.
Clin Endocrinol (Oxf). 81:665–670. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gejyo F, Ishida K and Arakawa M: Autosomal
dominant polycystic kidney disease complicated by primary
aldosteronism. Case report and review of the literature. Am J
Nephrol. 14:236–268. 1994. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kao CC, Wu VC, Kuo CC, Lin YH, Hu YH, Tsai
YC, Wu CH and Wu KD; TAIPAI study group, : Delayed diagnosis of
primary aldosteronism in patients with autosomal dominant
polycystic kidney diseases. J Renin Angiotensin Aldosterone Syst.
14:167–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Scheie HG: Evalution of ophthalmoscopic
changes of hypertension and arteriolar sclerosis. AMA Arch
Ophthalmol. 49:117–138. 1953. View Article : Google Scholar : PubMed/NCBI
|
9
|
O'Neill WC, Robbin ML, Bae KT, Grantham
JJ, Chapman AB, Guay-Woodford LM, Torres VE, King BF, Wetzel LH,
Thompson PA and Miller JP: Sonographic assessment of the severity
and progression of autosomal dominant polycystic kidney disease:
The consortium of renal imaging studies in polycystic kidney
disease (CRISP). Am J Kidney Dis. 46:1058–1064. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Cadnapaphornchai MA, McFann K, Strain JD,
Masoumi A and Schrier RW: Prospective change in renal volume and
function in children with ADPKD. Clin J Am Soc Nephrol. 4:820–829.
2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ravine D, Gibson RN, Walker RG, Sheffield
LJ, Kincaid-Smith P and Danks DM: Evaluation of ultrasonographic
diagnostic criteria for autosomal dominant polycystic kidney
disease 1. Lancet. 343:824–827. 1994. View Article : Google Scholar : PubMed/NCBI
|
12
|
Omura M, Sasano H, Saito J, Yamaguchi K,
Kakuta Y and Nishikawa T: Clinical characteristics of
aldosterone-producing microadenoma, macroadenoma, and idiopathic
hyperaldosteronism in 93 patients with primary aldosteronism.
Hypertens Res. 29:883–889. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Satoh F, Abe T, Tanemoto M, Nakamura M,
Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, et al:
Localization of aldosterone-producing adrenocortical adenomas:
Significance of adrenal venous sampling. Hypertens Res.
30:1083–1095. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Weiss LM: Comparative histologic study of
43 metastazing and nonmetastasizing adrenocortical tumors. Am J
Surg Pathol. 8:163–169. 1984. View Article : Google Scholar : PubMed/NCBI
|
15
|
Weiss LM, Medeiros LJ and Vickery AL Jr:
Pathologic features of prognostic significance in adrenocortical
carcinoma. Am J Surg Pathol. 13:202–206. 1989. View Article : Google Scholar : PubMed/NCBI
|
16
|
Matsuo S, Imai E, Horio M, Yasuda Y,
Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H and Hishida A:
Collaborators developing the Japanese equation for estimated GFR
Revised equations for estimated GFR from serum creatinine in Japan.
Am J Kidney Dis. 53:982–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Torres VE, Harris PC and Pirson Y:
Autosomal dominant polycystic kidney disease. Lancet.
369:1287–1301. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Parfrey PS, Bear JC, Morgan J, Cramer BC,
McManamon PJ, Gault MH, Churchill DN, Singh M, Hewitt R, Somlo S,
et al: The diagnosis and prognosis of autosomal dominant polycystic
kidney disease. N Engl J Med. 323:1085–1090. 1990. View Article : Google Scholar : PubMed/NCBI
|
19
|
Barrett BJ, Foley R, Morgan J, Hefferton D
and Parfrey P: Differences in hormonal and renal vascular responses
between normotensive patients with autosomal dominant polycystic
kidney disease and unaffected family members. Kidney Int.
46:1118–1123. 1994. View Article : Google Scholar : PubMed/NCBI
|
20
|
Bell PE, Hossack KF, Gabow PA, Durr JA,
Johnson AM and Schrier RW: Hypertension in autosomal dominant
polycystic kidney disease. Kidney Int. 34:683–690. 1988. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chapman AB, Johnson A, Gabow PA and
Schrier RW: The renin-angiotensin-aldosterone system and autosomal
dominant polycystic kidney disease. N Engl J Med. 323:1091–1096.
1990. View Article : Google Scholar : PubMed/NCBI
|
22
|
Peixoto AJ: A young patient with a family
history of hypertension. Clin J Am Soc Nephrol. 9:2164–2172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Bobrie G, Sirieix ME, Day M, Landais P,
Lacombe M and Grunfeld JP: Autosomal dominant polycystic kidney
disease with primary hyperaldosteronism. Nephrol Dial Transplant.
7:647–650. 1992. View Article : Google Scholar : PubMed/NCBI
|
24
|
Saeki S, Ogihara T, Masugi F, Mikami H,
Tabuchi Y, Seto T and Kumahara Y: A case of primary aldosteronism
with polycystic kidney disease. Nihon Naika Gakkai Zasshi.
75:28–32. 1986.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
25
|
Chee TS Rajasoorya and Ng BK: Hypertension
in disguise - a trap for the unwary. Eur J Endocrinol. 133:93–66.
1995. View Article : Google Scholar : PubMed/NCBI
|
26
|
Liou HH, Tsai SC, Chen WJ, Huang TP, Huang
WJ and Chen KK: The association of aldosterone-producing adrenal
adenoma in a patient with autosomal dominant polycystic kidney
disease. Am J Kidney Dis. 23:739–742. 1994. View Article : Google Scholar : PubMed/NCBI
|
27
|
Hoorn EJ, Hesselink DA, Kho MM, Roodnat
JI, Weimar W, van Saase JL, van den Meiracker AH and Zietse R: A
case of primary aldosteronism revealed after renal transplantation.
Nat Rev Nephrol. 7:55–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Chapman AB, Guay-Woodford LM, Grantham JJ,
Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner
JF, Wetzel LH, et al: Renal structure in early autosomal-dominant
polycystic kidney disease (ADPKD): The consortium for radiologic
imaging studies of polycystic kidney disease (CRISP) cohort. Kidney
Int. 64:1035–1045. 2003. View Article : Google Scholar : PubMed/NCBI
|
29
|
Torres VE and Harris PC: Autosomal
dominant polycystic kidney disease: The last 3 years. Kidney Int.
76:149–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Sarnak MJ, Greene T, Wang X, Beck G, Kusek
JW, Collins AJ and Levey AS: The effect of a lower target blood
pressure on the progression of kidney disease: Long-term follow-up
of the modification of diet in renal disease study. Ann Intern Med.
142:342–351. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Schrier RW, Abebe KZ, Perrone RD, Torres
VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki
PG, Hogan MC, et al: Blood pressure in early autosomal dominant
polycystic kidney disease. N Engl J Med. 371:2255–2266. 2014.
View Article : Google Scholar : PubMed/NCBI
|